25-hydroxyvitamin D₃ and 1,25-dihydroxyvitamin D₃ Promote the Differentiation of Human Subcutaneous Preadipocytes

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Dec 29

PMID 23272223

Citations 54

Authors

Hataikarn Nimitphong

Michael F Holick

Susan K Fried

Mi-Jeong Lee

Affiliations

Soon will be listed here.

Abstract

1,25(OH)(2)D(3) inhibits adipogenesis in mouse 3T3-L1 adipocytes, but little is known about its effects or local metabolism in human adipose tissue. We showed that vitamin D receptor (VDR) and 1α-hydroxylase (CYP27B1), the enzyme that activates 25(OH)D(3) to 1,25(OH)(2)D(3), were expressed in human adipose tissues, primary preadipocytes and newly-differentiated adipocytes. Preadipocytes and newly-differentiated adipocytes were responsive to 1,25(OH)(2)D(3), as indicated by a markedly increased expression of CYP24A1, a primary VDR target. 1,25(OH)(2)D(3) enhanced adipogenesis as determined by increased expression of adipogenic markers and triglyceride accumulation (50% to 150%). The magnitude of the effect was greater in the absence of thiazolidinediones. 1,25(OH)(2)D(3) was equally effective when added after the removal of differentiation cocktail on day 3, but it had no effect when added only during the induction period (day 0-3), suggesting that 1,25(OH)(2)D(3) promoted maturation. 25(OH)D(3) also stimulated CYP24A1 expression and adipogenesis, most likely through its conversion to 1,25(OH)(2)D(3). Consistent with this possibility, incubation of preadipocytes with 25(OH)D(3) led to 1,25(OH)(2)D(3) accumulation in the media. 1,25(OH)(2)D(3) also enhanced adipogenesis in primary mouse preadipocytes. We conclude that vitamin D status may regulate human adipose tissue growth and remodeling.

Citing Articles

Vitamin D Enhancement of Adipose Biology: Implications on Obesity-Associated Cardiometabolic Diseases.

Lee M Nutrients. 2025; 17(3).

PMID: 39940444 PMC: 11820181. DOI: 10.3390/nu17030586.

Vitamin D supplementation: Biochemical and inflammatory effects in non-pathological Wistar rats.

Muller de Moura Sarmento S, Gomes Schmitt E, Smolski Dos Santos L, Erminda Schreiner G, Tamborena Malheiros R, Klock C Toxicol Rep. 2025; 14:101901.

PMID: 39897401 PMC: 11786669. DOI: 10.1016/j.toxrep.2025.101901.

Interaction between Vitamin D homeostasis, gut microbiota, and central precocious puberty.

Guo D, Ning X, Bai T, Tan L, Zhou Y, Guo Z Front Endocrinol (Lausanne). 2024; 15:1449033.

PMID: 39717097 PMC: 11663660. DOI: 10.3389/fendo.2024.1449033.

Multifaceted Roles of Vitamin D for Diabetes: From Immunomodulatory Functions to Metabolic Regulations.

Park C, Shin S, Han S Nutrients. 2024; 16(18).

PMID: 39339785 PMC: 11435169. DOI: 10.3390/nu16183185.

Vitamin D Inadequacy and Its Relation to Body Fat and Muscle Mass in Adult Women of Childbearing Age.

Magalhaes P, Cruz S, Carneiro O, Teixeira M, Ramalho A Nutrients. 2024; 16(9).

PMID: 38732514 PMC: 11085628. DOI: 10.3390/nu16091267.

References

Tschop M, Speakman J, Arch J, Auwerx J, Bruning J, Chan L . A guide to analysis of mouse energy metabolism. Nat Methods. 2011; 9(1):57-63. PMC: 3654855. DOI: 10.1038/nmeth.1806. View

Looker A, Pfeiffer C, Lacher D, Schleicher R, Picciano M, Yetley E . Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008; 88(6):1519-27. PMC: 2745830. DOI: 10.3945/ajcn.2008.26182. View

Farmer S . Transcriptional control of adipocyte formation. Cell Metab. 2006; 4(4):263-73. PMC: 1958996. DOI: 10.1016/j.cmet.2006.07.001. View

Monkawa T, Yoshida T, Hayashi M, Saruta T . Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. Kidney Int. 2000; 58(2):559-68. DOI: 10.1046/j.1523-1755.2000.00202.x. View

Lou Y, Molnar F, Perakyla M, Qiao S, Kalueff A, St-Arnaud R . 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol. 2009; 118(3):162-70. DOI: 10.1016/j.jsbmb.2009.11.011. View

Blumberg J, Tzameli I, Astapova I, Lam F, Flier J, Hollenberg A . Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem. 2006; 281(16):11205-13. DOI: 10.1074/jbc.M510343200. View

Lee M, Wu Y, Fried S . A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes. Obesity (Silver Spring). 2012; 20(12):2334-40. PMC: 4320940. DOI: 10.1038/oby.2012.116. View

Tchkonia T, Lenburg M, Thomou T, Giorgadze N, Frampton G, Pirtskhalava T . Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab. 2006; 292(1):E298-307. DOI: 10.1152/ajpendo.00202.2006. View

Shi H, Norman A, Okamura W, Sen A, Zemel M . 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J. 2001; 15(14):2751-3. DOI: 10.1096/fj.01-0584fje. View

10.

Kelly K, Gimble J . 1,25-Dihydroxy vitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology. 1998; 139(5):2622-8. DOI: 10.1210/endo.139.5.5970. View

11.

Liu P, Stenger S, Li H, Wenzel L, Tan B, Krutzik S . Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311(5768):1770-3. DOI: 10.1126/science.1123933. View

12.

White U, Stephens J . Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol. 2009; 318(1-2):10-4. PMC: 3079373. DOI: 10.1016/j.mce.2009.08.023. View

13.

Sigmundsdottir H, Pan J, Debes G, Alt C, Habtezion A, Soler D . DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol. 2007; 8(3):285-93. DOI: 10.1038/ni1433. View

14.

Wong K, Szeto F, Zhang W, Ye H, Kong J, Zhang Z . Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab. 2009; 296(4):E820-8. PMC: 2670625. DOI: 10.1152/ajpendo.90763.2008. View

15.

Ching S, Kashinkunti S, Niehaus M, Zinser G . Mammary adipocytes bioactivate 25-hydroxyvitamin D₃ and signal via vitamin D₃ receptor, modulating mammary epithelial cell growth. J Cell Biochem. 2011; 112(11):3393-405. PMC: 3196822. DOI: 10.1002/jcb.23273. View

16.

Lenders C, Feldman H, von Scheven E, Merewood A, Sweeney C, Wilson D . Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr. 2009; 90(3):459-67. PMC: 2728638. DOI: 10.3945/ajcn.2008.27275. View

17.

Siersbaek R, Nielsen R, John S, Sung M, Baek S, Loft A . Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 2011; 30(8):1459-72. PMC: 3102274. DOI: 10.1038/emboj.2011.65. View

18.

Lorente-Cebrian S, Eriksson A, Dunlop T, Mejhert N, Dahlman I, Astrom G . Differential effects of 1α,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur J Nutr. 2011; 51(3):335-42. DOI: 10.1007/s00394-011-0218-z. View

19.

Kong J, Li Y . Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab. 2005; 290(5):E916-24. DOI: 10.1152/ajpendo.00410.2005. View

20.

Nagpal S, Na S, Rathnachalam R . Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005; 26(5):662-87. DOI: 10.1210/er.2004-0002. View